<DOC>
	<DOCNO>NCT00669474</DOCNO>
	<brief_summary>Part 1 : patient essential hyperhidrosis treat one time suction curettage axilla . Part 2 : patient axillary hyperhidrosis receive one treatment suction curettage one axilla , time one treatment BOTOX injection axilla .</brief_summary>
	<brief_title>Unicentric Comparing Study Suction Curettage With Standard BOTOX Injection Treatment Patients With Essential Axillar Hyperhidrosis : Comparing Efficacy , Duration Effectiveness , Adverse Events .</brief_title>
	<detailed_description />
	<mesh_term>Hyperhidrosis</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>18 75 year Persistent bilateral primary axillary hyperhidrosis Hidrosis interfere daily activity patient Gravimetrically minimal 50 mg spontaneous sweat production axilla , measure 5 minute room temperature calm condition sign informed consent patient shall continue trial end , follow instruction correcly woman reproductive period pregnancy test Medical condition dangerous treatment BOTOX , include myastenia gravis , LambertEaton syndrome , ALS , disease interfere neuromuscular function Secundary hyperhidrosis ( example secundary hyperthyroid problem , lymfoma , malaria ) Known allergy study medication , component , local anesthesia iodium Use aminoglycosids , curarelike product , product interfere neuromuscular function study Use therapy hyperhidrosis Aluminium chlorid study Infection skin disease area treat Participation therapeutic study time Botuline toxine treatment last 4 month Women want become pregnant Women reproductive period n't use appropriate contraception Patients situation researcher decide dangerous , interfere study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>